Large Cell Neuroendocrine Carcinoma
Also known as: Large-Cell Neuroendocrine Carcinoma / Large cell neuroendocrine carcinoma (morphologic abnormality)
Drug | Drug Name | Drug Description |
---|
Drug | Drug Name | Target | Type |
---|
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB01234 | Dexamethasone | 1 / 2 | Terminated | 1 |
DB13017 | Rovalpituzumab tesirine | 1 / 2 | Terminated | 1 |
DB08875 | Cabozantinib | 2 | Recruiting | 1 |
DB06186 | Ipilimumab | 2 | Recruiting | 1 |
DB09035 | Nivolumab | 2 | Active Not Recruiting | 1 |
DB09035 | Nivolumab | 2 | Recruiting | 1 |
DB00853 | Temozolomide | 2 | Active Not Recruiting | 1 |